Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jet-Injection Assisted Photodynamic Therapy for Basal Cell Carcinoma
NCT04552990Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 2020
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of 5-aminolevulinic acid in basal cell carcinoma (BCC) (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Clinical Evaluation of Local Skin Responses at 3 months. Started Sep 2020; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT04552990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04552990.